Follow
Tavé van Zyl, MD
Tavé van Zyl, MD
Instructor in Ophthalmology, Harvard Medical School
Verified email at meei.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Molecular classification and comparative taxonomics of foveal and peripheral cells in primate retina
YR Peng, K Shekhar, W Yan, D Herrmann, A Sappington, GS Bryman, ...
Cell 176 (5), 1222-1237. e22, 2019
3722019
Cell atlas of the human fovea and peripheral retina
W Yan, YR Peng, T van Zyl, A Regev, K Shekhar, D Juric, JR Sanes
Scientific reports 10 (1), 9802, 2020
1612020
Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis
T van Zyl, W Yan, A McAdams, YR Peng, K Shekhar, A Regev, D Juric, ...
Proceedings of the National Academy of Sciences 117 (19), 10339-10349, 2020
1202020
Identification of RUNX1 as a mediator of aberrant retinal angiogenesis
JD Lam, DJ Oh, LL Wong, D Amarnani, C Park-Windhol, AV Sanchez, ...
Diabetes 66 (7), 1950-1956, 2017
652017
Identifying barriers to follow-up eye care for children after failed vision screening in a primary care setting
Z Su, EK Marvin, BQ Wang, T van Zyl, MD Elia, EN Garza, DJ Salchow, ...
Journal of American Association for Pediatric Ophthalmology and Strabismus …, 2013
492013
Endophthalmitis after intravitreal injections in patients with self-reported iodine allergy
BS Modjtahedi, T van Zyl, HK Pandya, RE Leonard II, D Eliott
American journal of ophthalmology 170, 68-74, 2016
422016
Cell atlas of the human ocular anterior segment: Tissue-specific and shared cell types
T van Zyl, W Yan, AM McAdams, A Monavarfeshani, GS Hageman, ...
Proceedings of the National Academy of Sciences 119 (29), e2200914119, 2022
412022
Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
TD Papakostas, L Lim, T Van Zyl, JB Miller, BS Modjtahedi, CM Andreoli, ...
Eye 30 (1), 79-84, 2016
372016
Characteristics and outcomes of endogenous endophthalmitis: eight-year experience at a tertiary care center
BS Modjtahedi, AP Finn, SM Barb, MJ MacLachlan, T van Zyl, ...
Ophthalmology Retina 3 (1), 61-72, 2019
332019
Providing prescheduled appointments as a strategy for improving follow-up compliance after community-based glaucoma screening: results from an urban underserved population
T van Zyl, Z Su, E Zhou, RK Wong, A Mohsenin, S Rogers, JC Tsai, ...
Journal of community health 40, 27-33, 2015
192015
Incidence of management changes at the postoperative week 1 visit after cataract surgery: results from the Perioperative Care for IntraOcular Lens Study
DS Borkar, I Laíns, EA Eton, N Koulisis, GA Moustafa, T van Zyl, CE Kloek, ...
American journal of ophthalmology 199, 94-100, 2019
142019
Cell atlas of the human fovea and peripheral retina. Sci Rep 10: 9802
W Yan, YR Peng, T van Zyl, A Regev, K Shekhar, D Juric, JR Sanes
132020
Efficacy of a single administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis
T Than, CE Morettin, JS Harthan, ATE Hartwick, JB Huecker, SD Johnson, ...
American journal of ophthalmology 231, 28-38, 2021
112021
ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma
K Praveen, GC Patel, L Gurski, AH Ayer, T Persaud, MD Still, L Miloscio, ...
Communications biology 5 (1), 1051, 2022
92022
Treatment course of patients with exudative age-related macular degeneration using ocular hypotensives
BS Modjtahedi, TQ Luong, S Chiu, T van Zyl, JC Lin, DS Fong
Clinical Ophthalmology, 187-195, 2020
72020
Management of open globe injuries
S Grob, C Kloek
Springer International Publishing, 2018
62018
Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma
AR Hamel, W Yan, JM Rouhana, A Monovarfeshani, X Jiang, PA Mehta, ...
Nature Communications 15 (1), 396, 2024
52024
Transcriptomic analysis of the ocular posterior segment completes a cell atlas of the human eye
A Monavarfeshani, W Yan, C Pappas, KA Odenigbo, Z He, AV Segrè, ...
Proceedings of the National Academy of Sciences 120 (34), e2306153120, 2023
42023
Interim analysis of an open-label, ascending-dose, phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of the subcutaneously …
T van Zyl, J Weyne, U Chaudhari, O Harari, O Levy, J Miller, Y Chen, ...
Blood 138, 1998, 2021
32021
Outcomes and practice preferences after endophthalmitis following anti-VEGF intravitreal injection
Y Chen, GK Shah, V Shah, KJ Blinder, AM Jeroudi, A Leonard, M Gilca, ...
Journal of VitreoRetinal Diseases 3 (6), 411-419, 2019
32019
The system can't perform the operation now. Try again later.
Articles 1–20